As of 2024-12-13, the Intrinsic Value of Evelo Biosciences Inc (EVLO) is
-22,881.90 USD. This EVLO valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.32 USD, the upside of Evelo Biosciences Inc is
-7,229,768.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-22,881.90 USD
Intrinsic Value
EVLO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-22,881.90 - -22,881.90 |
-22,881.90 |
-7,229,768.00% |
| P/E |
(23,339.52) - (83,747.69) |
(53,886.84) |
-17025956.4% |
| DDM - Stable |
(10.81) - (22.14) |
(16.47) |
-5304.0% |
| DDM - Multi |
(15.78) - (22.43) |
(18.44) |
-5924.8% |
EVLO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
0.01 |
| Beta |
73.50 |
| Outstanding shares (mil) |
0.02 |
| Enterprise Value (mil) |
16.61 |
| Market risk premium |
4.60% |
| Cost of Equity |
24,130.96% |
| Cost of Debt |
5.00% |
| WACC |
8.13% |